In The News
Dr. Reddy’s Laboratories Announces the Sale of Cloderm® (clocortolone pivalate) Cream, 0.1% Franchise to EPI Health, LLC
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY along with its subsidiaries together referred to as “Dr. Reddy’s”) announced today that its wholly owned subsidiary Promius Pharma, LLC, has...
EPI Health, LLC signs Agreement With SMG Pharmaceuticals to Promote BENSAL HP®
CHARLESTON, S.C., July 26, 2017 /PRNewswire/ -- EPI Health LLC ("EPIH" or the "Company"), a specialty pharmaceutical company wholly owned by EPI Group LLC, announced an agreement with SMG Pharmaceuticals Inc. ("SMG") to market and sell BENSAL HP®. EPIH relaunched the...
Evening Post Industries acquires Charleston-based pharmaceutical business in bid to diversify holdings
The parent company of The Post and Courier is making moves into the pharmaceutical industry, buying a Charleston-based business that markets and sells treatments for skin conditions in a deal potentially worth almost $14.4 million. Evening Post Industries LLC paid...